Citations

Citations to this article as recorded by  

• Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
  Andrey V. Markov, Arseny D. Moralev, Kirill V. Odarenko
  Biomedicines.2025; 13(1): 133.     CrossRef
• Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
  Jian Li, Xin Li, Hongwei Liu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
  Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi
  Biomolecules.2025; 15(2): 268.     CrossRef
• Cumin (Cuminum cyminum L.) seeds accelerates wound healing in rats: Possible molecular mechanisms
  Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Yaseen Galali, Ayman M. Al‐Qaaneh, Gökhan Akçakavak, Nur Ain Salehen, Rawaz Rizgar Hassan, Ramzi A. Mothana, Mahmood Ameen Abdulla, Omer I. Fantoukh, Sidig Hasson, Mohammed F. Hawwal
  Skin Research and Technology.2024;[Epub]     CrossRef
• TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance
  Allan M. Johansen, Steven D. Forsythe, Callum T. McGrath, Grayson Barker, Hugo Jimenez, Ravi K. Paluri, Boris C. Pasche
  Clinical Cancer Research.2024; 30(17): 3676.     CrossRef
• NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets
  Ashkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, Sina Sadati, Arash Raisi, AmirMohammad Abolhassani, Reza Eshraghi, Mahmood Khaksary Mahabady, Neda Rahimian, Hamed Mirzaei
  European Journal of Medical Research.2024;[Epub]     CrossRef
• Bitter taste signaling in cancer
  Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
  Life Sciences.2023; 315: 121363.     CrossRef
• Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
  Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
  Cell Biology International.2023; 47(9): 1638.     CrossRef
• Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
  Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
  Life Sciences.2023; 331: 122037.     CrossRef
• TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
  Sumeet Singh, Vinita Gouri, Mukesh Samant
  Medical Oncology.2023;[Epub]     CrossRef
• The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
  Tao An, Huanhuan Yin, Yanting Lu, Feng Liu
  Drug Design, Development and Therapy.2022; Volume 16: 1255.     CrossRef
• Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
  Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
  Life Sciences.2022; 301: 120610.     CrossRef
• Cinnamomum bejolghota Extract Inhibits Colorectal Cancer Cell Metastasis and TGF-β1-Induced Epithelial-Mesenchymal Transition via Smad and Non-Smad Signaling Pathway
  Athicha Kittiwattanokhun, Sukanda Innajak, Etsu Tashiro, Masaya Imoto, Ramida Watanapokasin
  Scientia Pharmaceutica.2022; 90(2): 30.     CrossRef
• Autoimmunity and Cancer—Two Sides of the Same Coin
  Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom, Natalia Marek-Trzonkowska, Piotr Trzonkowski
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
  Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Plants as a Source of Anticancer Agents: From Bench to Bedside
  Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, Reem Ali Hamed, Dima Awajan, Sara Feras Abuarab, Lena Hisham Odeh, Samar Khater, Lina T. Al Kury
  Molecules.2022; 27(15): 4818.     CrossRef
• Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
  Nima Zafari, Mahla Velayati, Mohammadreza Nassiri, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan
  Current Pharmaceutical Design.2022; 28(28): 2298.     CrossRef
• The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities
  Rubén Varela‐Calviño, Marta Rodríguez‐Quiroga, Patrícia Dias Carvalho, Flavia Martins, André Serra‐Roma, Lorena Vázquez‐Iglesias, María Páez de la Cadena, Sérgia Velho, Oscar J. Cordero
  IUBMB Life.2021; 73(5): 761.     CrossRef

• Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF

  
  Bo Tian, Yuhang Xiao, Junliang Ma, Wei Ou, Hui Wang, Jie Wu, Jinming Tang, Baihua Zhang, Xiaojuan Liao, Desong Yang, Zhining Wu, Xu Li, Yong Zhou, Min Su, Wenxiang Wang
  OncoTargets and Therapy.2020; Volume 13: 7447.     CrossRef
• Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
  Alex S. Quy, Xingjian Li, Louise Male, Tatjana Stankovic, Angelo Agathanggelou, John S. Fossey
  Tetrahedron.2020; : 131631.     CrossRef
• Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
  Chang Hoon Lee
  Cancers.2019; 11(12): 1841.     CrossRef

Citations

Citations to this article as recorded by  

• Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
  Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi
  Biomolecules.2025; 15(2): 268.     CrossRef
• Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
  Jian Li, Xin Li, Hongwei Liu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Cyanidin-3-O-glucoside inhibits the malignant progression of colorectal cancer by regulating Kruppel-like factor 4-mediated ERK/p38 signaling pathway
  Jian Chang, Geqiong Xiao
  Toxicology and Applied Pharmacology.2025; 497: 117268.     CrossRef
• Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro
  Parisa Karimian Ensaf, Mohammad Taghi Goodarzi, Masoud Homayouni Tabrizi, Ali Neamati, Samira Sadat Hosseinyzadeh
  Molecular Biology Reports.2024;[Epub]     CrossRef
• Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
  Chou-Yi Hsu, Sadegh Rajabi, Maryam Hamzeloo-Moghadam, Abhinav Kumar, Marc Maresca, Pallavi Ghildiyal
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Exploring the Phytochemistry, Signaling Pathways, and Mechanisms of Action of Tanacetum parthenium (L.) Sch.Bip.: A Comprehensive Literature Review
  Ali Kashkooe, Atefeh Jalali, Mohammad M. Zarshenas, Azadeh Hamedi
  Biomedicines.2024; 12(10): 2297.     CrossRef
• Bitter taste signaling in cancer
  Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
  Life Sciences.2023; 315: 121363.     CrossRef
• Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
  Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
  Cell Biology International.2023; 47(9): 1638.     CrossRef
• Novel shikonin derivative suppresses tumor growth and metastasis intervention of Wnt/β-catenin pathway
  Hongwei Han, Zhongling Wen, Xiaohui Lai, Minkai Yang, Jiangyan Fu, Liangjie Yang, Qingqing Chen, Yudi Ma, Wencai Jie, Changyi Wang, Tongming Yin, Guihua Lu, Xiaoming Wang, Shucun Sun, Quan Zhao, Jinliang Qi, Hongyan Lin, Yonghua Yang
  Process Biochemistry.2023; 132: 297.     CrossRef
• Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
  Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
  Life Sciences.2023; 331: 122037.     CrossRef
• TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
  Sumeet Singh, Vinita Gouri, Mukesh Samant
  Medical Oncology.2023;[Epub]     CrossRef
• Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers
  Beste Turanli
  OMICS: A Journal of Integrative Biology.2023; 27(10): 483.     CrossRef
• Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
  Daniela Carlisi, Marianna Lauricella, Antonella D’Anneo, Anna De Blasio, Adriana Celesia, Giovanni Pratelli, Antonietta Notaro, Giuseppe Calvaruso, Michela Giuliano, Sonia Emanuele
  Biomedicines.2022; 10(2): 514.     CrossRef
• Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
  Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
  Life Sciences.2022; 301: 120610.     CrossRef
• Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
  Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
  Xingchen LIU, Xiaobing WANG
  Chinese Journal of Natural Medicines.2022; 20(11): 814.     CrossRef
• Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
  Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
  Cancers.2021; 13(8): 1786.     CrossRef
• Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
  Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J. Dyson, Jean-Luc Wolfender, Patrycja Nowak-Sliwinska
  Cancers.2021; 13(16): 3978.     CrossRef
• 6 α-Hydroxy-4[14], 10[15]-guainadien-8β, 12-olide induced cell cycle arrest via modulation of EMT and Wnt/β-catenin pathway in HER-2 positive breast cancer cells
  Gitanjali Javir, Kalpana Joshi, Vijay Khedkar, Supada Rojatkar
  The Journal of Steroid Biochemistry and Molecular Biology.2020; 197: 105514.     CrossRef
• Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth
  Xue Li, Lingmei Kong, Qihong Yang, Aizhu Duan, Xiaoman Ju, Bicheng Cai, Lin Chen, Tao An, Yan Li
  Journal of Biological Chemistry.2020; 295(11): 3576.     CrossRef
• Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity
  Lili Yuan, Zhe Wang, Dongyang Zhang, Jiahe Wang
  Journal of Chromatography B.2020; 1150: 122179.     CrossRef
• ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
  Xiao‐Han Jin, Yong‐Sheng Jia, Ye‐Hui Shi, Qiu‐Ying Li, Shi‐Qi Bao, Wen‐Ping Lu, Zhong‐Sheng Tong
  Journal of Cellular Biochemistry.2019; 120(2): 1386.     CrossRef
• Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
  Mona Dawood, Edna Ooko, Thomas Efferth
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
  Shi Mao Zhu, Yong Ran Park, Seung Yong Seo, In Hee Kim, Soo Teik Lee, Sang Wook Kim
  Intestinal Research.2019; 17(4): 527.     CrossRef
• Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
  Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
  Antioxidants & Redox Signaling.2018; 29(13): 1237.     CrossRef
• Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
  Wamidh H. Talib, Lina T. Al Kury
  Biomedicine & Pharmacotherapy.2018; 107: 1488.     CrossRef
• Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
  Sen Jiang, Kun Zhang, Yan He, Xuetao Xu, Dongli Li, Shupeng Cheng, Xi Zheng
  RSC Advances.2018; 8(5): 2768.     CrossRef
• The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
  Xin Jin, Jianping Zhou, Zhenhai Zhang, Huixia Lv
  Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup3): 931.     CrossRef

Citations

Citations to this article as recorded by  

• Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
  Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
  Cancers.2021; 13(8): 1786.     CrossRef
• Computational investigation of FDA approved drugs as selective PARP-1 inhibitors by targeting BRCT domain for cancer therapy
  Chandan Kumar, P.T.V. Lakshmi, Annamalai Arunachalam
  Journal of Molecular Graphics and Modelling.2021; 108: 107919.     CrossRef
• Identification of Autophagy-Associated Biomarkers and Corresponding Regulatory Factors in the Progression of Colorectal Cancer
  Chunrui Zhang, Jing Jiang, Liqiang Wang, Liyu Zheng, Jiankai Xu, Xiaolin Qi, Huiying Huang, Jianping Lu, Kongning Li, Hong Wang
  Frontiers in Genetics.2020;[Epub]     CrossRef
• Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
  Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
  Molecular Biology Reports.2020; 47(8): 5807.     CrossRef
• Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
  Malgorzata Sztiller-Sikorska, Malgorzata Czyz
  Pharmaceuticals.2020; 13(8): 194.     CrossRef
• Integration of genetic variants and gene network for drug repurposing in colorectal cancer
  Lalu Muhammad Irham, Henry Sung-Ching Wong, Wan-Hsuan Chou, Wirawan Adikusuma, Eko Mugiyanto, Wan-Chen Huang, Wei-Chiao Chang
  Pharmacological Research.2020; 161: 105203.     CrossRef
• Synthesis of azo dyes possessing N-heterocycles and evaluation of their anticancer and antibacterial properties
  Zarrin Ghasemi, Sajjad Azizi, Roya Salehi, Hossein Samadi Kafil
  Monatshefte für Chemie - Chemical Monthly.2018; 149(1): 149.     CrossRef
• Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
  Xiao-he Li, Ting Xiao, Jia-huan Yang, Yuan Qin, Jing-jing Gao, Hui-juan Liu, Hong-gang Zhou
  Respiratory Research.2018;[Epub]     CrossRef
• Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
  Eun-Kyung Kim, Jae Hee Cho, EuiJoo Kim, Yoon Jae Kim, Aamir Ahmad
  PLOS ONE.2017; 12(7): e0181183.     CrossRef
• Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer
  Arpit Saxena, Raja Fayad, Kamaljeet Kaur, Samantha Truman, Julian Greer, James A. Carson, Anindya Chanda
  Cancer Biology & Therapy.2017; 18(4): 257.     CrossRef
• Sesquiterpene binding Gly-Leu-Ser/Lys-“co-adaptation pocket” to inhibit lung cancer cell epithelial-mesenchymal transition
  Xiao-Yu Ai, Heng Zhang, Shao-Yan Gao, Yuan Qin, Wei-Long Zhong, Ju Gu, Meng Li, Kai-Liang Qiao, Qin Tian, Zhan-Hong Cui, Jia-Huan Yang, Zhun Bi, Ting Xiao, Shuang Chen, Hui-Juan Liu, Hong-Gang Zhou, Tao Sun, Cheng Yang
  Oncotarget.2017; 8(41): 70192.     CrossRef
• Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
  Liang Chen, Ya-Qiong Xiong, Jing Xu, Ji-Peng Wang, Zi-Li Meng, Yong-Qing Hong
  Oncotarget.2017; 8(55): 93878.     CrossRef
• Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway
  Xianjin Zhu, Yanfang Song, Conglian Wu, Chuxi Pan, Pingxia Lu, Meihua Wang, Peizheng Zheng, Rongfen Huo, Chenqing Zhang, Wanting Li, Yulin Lin, Yingping Cao, Ningli Li
  Scientific Reports.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Nanomagnetic Liposome-Encapsulated Parthenolide and Indocyanine Green for Targeting and Chemo-Photothermal Antitumor Therapy
  Wenbin Gao, Lei Li, Xuwu Zhang, Liyao Luo, Yuchu He, Cong Cong, Dawei Gao
  Nanomedicine.2020; 15(9): 871.     CrossRef
• Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy
  Wenbin Gao, Shipan Wei, Zhuo Li, Lei Li, Xuwu Zhang, Chunhui Li, Dawei Gao
  Nanotechnology.2020; 31(35): 355104.     CrossRef
• Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
  Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
  Molecular Biology Reports.2020; 47(8): 5807.     CrossRef
• Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
  Malgorzata Sztiller-Sikorska, Malgorzata Czyz
  Pharmaceuticals.2020; 13(8): 194.     CrossRef
• Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
  Ali Hassanzadeh, Majid Farshdousti Hagh, Mohammad Reza Alivand, Ali Akbar Movassaghpour Akbari, Karim Shams Asenjan, Raedeh Saraei, Saeed Solali
  Journal of Cellular Physiology.2018; 233(10): 6470.     CrossRef
• Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
  Gabriela Flores‐Lopez, Dafne Moreno‐Lorenzana, Manuel Ayala‐Sanchez, Socrates Aviles‐Vazquez, Hector Torres‐Martinez, Peter A. Crooks, Monica L. Guzman, Hector Mayani, Antonieta Chávez‐González
  Journal of Cellular and Molecular Medicine.2018; 22(10): 4899.     CrossRef
• Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation
  Se-Lim Kim, Seong Hun Kim, Young Ran Park, Yu-Chuan Liu, Eun-Mi Kim, Hwan-Jeong Jeong, Yo Na Kim, Seung Young Seo, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang-Wook Kim
  Molecular Cancer Research.2017; 15(2): 141.     CrossRef
• Protective effects of Alpha-lipoic acid on MeHg-induced oxidative damage and intracellular Ca2+dyshomeostasis in primary cultured neurons
  Tianyao Yang, Zhaofa Xu, Wei Liu, Bin Xu, Yu Deng
  Free Radical Research.2016; 50(5): 542.     CrossRef
• Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats
  Gracianny Gomes Martins, Francislaine Aparecida dos Reis Lívero, Aline Maria Stolf, Caroline Machado Kopruszinski, Cibele Campos Cardoso, Olair Carlos Beltrame, José Ederaldo Queiroz-Telles, Regiane Lauriano Batista Strapasson, Maria Élida Alves Stefanell
  Chemico-Biological Interactions.2015; 228: 46.     CrossRef
• Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
  Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
  Intestinal Research.2015; 13(3): 233.     CrossRef
• Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation
  THANET SOPHONNITHIPRASERT, SIRINUN NILWARANGKOON, YUKIO NAKAMURA, RAMIDA WATANAPOKASIN
  International Journal of Oncology.2015; 47(6): 2188.     CrossRef